Uterine Cervical Neoplasms

• 

  Subject Areas on Research

  • "You just do your part. God will do the rest.": spirituality and culture in the medical encounter. 
  • 'I'm here to save my life': a qualitative study of experiences navigating a cryotherapy referral system for human papillomavirus-positive women in western Kenya. 
  • 6-Methylene progesterone is cytotoxic to human cancer cell lines independent of its 5-alpha-reductase activity. 
  • A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: a Gynecologic Oncology Group study. 
  • A Qualitative Exploration of Women's Experiences with a Community Health Volunteer-Led Cervical Cancer Educational Module in Migori County, Kenya. 
  • A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy. 
  • A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya. 
  • A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program. 
  • A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types. 
  • A novel speculum-free imaging strategy for visualization of the internal female lower reproductive system. 
  • A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study. 
  • A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. 
  • A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. 
  • A pri-miR-218 variant and risk of cervical carcinoma in Chinese women. 
  • A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women. 
  • A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening. 
  • Abnormal Fhit expression in malignant and premalignant lesions of the cervix. 
  • Abnormal outcomes following cervical cancer screening: event duration and health utility loss. 
  • Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. 
  • Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. 
  • Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya. 
  • Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. 
  • Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. 
  • Adolescent girls' preferences for HPV vaccines: a discrete choice experiment. 
  • Advanced Treatment Technique for Locally Advanced Cervical Cancer: Time for a Standard of Care Shift? 
  • Advances in quantitative UV-visible spectroscopy for clinical and pre-clinical application in cancer. 
  • Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. 
  • Age-specific occurrence of HPV16- and HPV18-related cervical cancer. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • An integrated strategy for improving contrast, durability, and portability of a Pocket Colposcope for cervical cancer screening and diagnosis. 
  • Analysis of results of radiation therapy for Stage II carcinoma of the cervix. 
  • Analysis of results of radiation therapy for stage IB carcinoma of the cervix. 
  • Are supportive care-based treatment strategies preferable to standard chemotherapy in recurrent cervical cancer? 
  • Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults. 
  • Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy. 
  • Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer. 
  • Associations between religion-related factors and cervical cancer screening among Muslims in greater chicago. 
  • Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. 
  • Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. 
  • Authors' reply: Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study: population and statistical queries. 
  • Awareness of Cervical Cancer Causes and Predeterminants of Likelihood to Screen Among Women in Haiti. 
  • Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care. 
  • Barriers to Breast and Cervical Cancer Screening in Singapore: a Mixed Methods Analysis. 
  • Barriers to Cervical Cancer Screening in Rural Kenya: Perspectives from a Provider Survey. 
  • Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program. 
  • Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective? 
  • Bilateral pelvic lymph node metastases in a case of FIGO stage IA(1) adenocarcinoma of the cervix. 
  • Blue nevus of the cervix. 
  • Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. 
  • CASP7 variants modify susceptibility to cervical cancer in Chinese women. 
  • CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines. 
  • Can screening older patients for cancer save lives? 
  • Cancer Screening Results and Follow-up Using Routinely Collected Electronic Health Data: Estimates for Breast, Colon, and Cervical Cancer Screenings. 
  • Cancer risk in women exposed to diethylstilbestrol in utero. 
  • Cancer screening behaviors and attitudes of women in southeastern Minnesota. 
  • Cancer screening in the elderly. 
  • Cancer screening practices among women in a community health center population. 
  • Carcinoma of the cervix, stage III. Results of radiation therapy. 
  • Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications. 
  • Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. 
  • Carcinoma of the uterine cervix: a 3D - CT analysis of dose to the internal, external and common iliac nodes in tandem and ovoid applications. 
  • Cardiac metastasis from carcinoma of the cervix: report of two cases. 
  • Cell cycle studies of cyclocreatine, a new anticancer agent. 
  • Cervical Cancer Screening Knowledge and Behavior among Women Attending an Urban HIV Clinic in Western Kenya. 
  • Cervical Cancer Screening. 
  • Cervical Cancer Stigma in Rural Kenya: What Does HIV Have to Do with It? 
  • Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Cervical adenoid cystic carcinoma associated with ascites. 
  • Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods. 
  • Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. 
  • Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya. 
  • Cervical cancer. 
  • Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imaging. 
  • Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count. 
  • Cervical intraepithelial neoplasia in HIV-infected women in a southeastern US population. 
  • Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. 
  • Changes in insurance coverage for cancer patients receiving brachytherapy before and after enactment of the Affordable Care Act. 
  • Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis. 
  • Changing knowledge, attitudes, and behaviors regarding cervical cancer screening: The effects of an educational intervention in rural Kenya. 
  • Chapter 19: Cost-effectiveness of cervical cancer screening. 
  • Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol. 
  • Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. 
  • Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. 
  • Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. 
  • Clinicopathologic study of 85 cases of melanoma of the female genitalia. 
  • Coital risk factors for cervical cancer. Sexual activity among white middle class women. 
  • Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions. 
  • Combining multiple contrasts for improving machine learning-based classification of cervical cancers with a low-cost point-of-care Pocket colposcope. 
  • Comparison of histologic and colposcopic findings in DES-exposed females. 
  • Comparison of patient flow and provider efficiency of two delivery strategies for HPV-based cervical cancer screening in Western Kenya: a time and motion study. 
  • Comparison of the costs of HPV testing through community health campaigns versus home-based testing in rural Western Kenya: a microcosting study. 
  • Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses. 
  • Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer. 
  • Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix. 
  • Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya. 
  • Cost-Effectiveness of High-Risk Human Papillomavirus Testing With Messenger RNA Versus DNA Under United States Guidelines for Cervical Cancer Screening. 
  • Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). 
  • Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. 
  • Cost-effectiveness of a potential vaccine for human papillomavirus. 
  • Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery. 
  • Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery. 
  • Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. 
  • Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis. 
  • Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors. 
  • Cystic fibrosis involving the cervix, mimicking a well-differentiated adenocarcinoma: a case report. 
  • Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis. 
  • Cytologic features of adenocarcinoma, not otherwise specified, in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Cytologic features of squamous cell carcinoma in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. 
  • DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions. 
  • DNA polymerase ζ as a potential biomarker of chemoradiation resistance and poor prognosis for cervical cancer. 
  • Data-Derived Treatment Duration Goal for Cervical Cancer: Should 8 Weeks Remain the Target in the Era of Concurrent Chemoradiation? 
  • De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam. 
  • Decision science and cervical cancer. 
  • Demand for Cancer Screening Services: Results From Randomized Controlled Discrete Choice Experiments. 
  • Design and preliminary analysis of a vaginal inserter for speculum-free cervical cancer screening. 
  • Design of a Novel Low Cost Point of Care Tampon (POCkeT) Colposcope for Use in Resource Limited Settings. 
  • Design of a plastic minicolpostat applicator with shields. 
  • Development of Algorithms for Automated Detection of Cervical Pre-Cancers With a Low-Cost, Point-of-Care, Pocket Colposcope. 
  • Differences between univariate and bivariate models for summarizing diagnostic accuracy may not be large. 
  • Disparities in Cervical Cancer Incidence and Mortality: Can Epigenetics Contribute to Eliminating Disparities? 
  • Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer? 
  • Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. 
  • Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States. 
  • Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. 
  • Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. 
  • Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study. 
  • Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis. 
  • Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study. 
  • Evaluating a stage model in predicting monolingual spanish-speaking Latinas' cervical cancer screening practices: the role of psychosocial and cultural predictors. 
  • Evaluating human papillomavirus vaccination programs. 
  • Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling. 
  • Evaluation of cervical cytology. 
  • Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. 
  • Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer. 
  • Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader. 
  • Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. 
  • FDG-PET for management of cervical and ovarian cancer. 
  • Factors affecting compliance with clinical practice guidelines for pap smear screening among healthcare providers in africa: systematic review and meta-summary of 2045 individuals. 
  • Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. 
  • Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya. 
  • Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology. 
  • Female perspectives on male involvement in a human-papillomavirus-based cervical cancer-screening program in western Kenya. 
  • Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. 
  • Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. 
  • Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes. 
  • GSTM1 polymorphism, GSTT1 polymorphism, and cervical cancer risk: a meta-analysis. 
  • Genetic profiling to predict recurrence of early cervical cancer. 
  • Glassy cell carcinoma of the cervix. 
  • Goblet-cell mucinous epithelium lining the endometrium and endocervix: evidence of metastasis from an appendiceal primary tumor through the use of cytokeratin-7 and -20 immunostains. 
  • Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection. 
  • HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA. 
  • HPV vaccines: now that they're here, how do we maximize their benefit? 
  • HPV-based cervical cancer screening in low-resource settings: Maximizing the efficiency of community-based strategies in rural Kenya. 
  • Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey. 
  • Health economics of screening for gynaecological cancers. 
  • Health promotion interventions for disadvantaged women: overview of the WISEWOMAN projects. 
  • High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease. 
  • High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins. 
  • High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible? 
  • Histologic, nuclear DNA, and human papillomavirus studies of cervical condylomas. 
  • Hospitalization outcomes and racial disparities in cervical cancer patients: An analysis of the national inpatient sample data from 2002 to 2014. 
  • How Providing Cervical Cancer Screening Results via Cell Phone Affects Patient Follow-Up Rates in Western Kenya. 
  • How does information on the harms and benefits of cervical cancer screening alter the intention to be screened?: a randomized survey of Norwegian women. 
  • Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. 
  • Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program. 
  • Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. 
  • Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis. 
  • Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. 
  • Hyperchromatic crowded groups in cervical cytology--differing appearances and interpretations in conventional and ThinPrep preparations: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. 
  • Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? 
  • Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. 
  • Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. 
  • Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis. 
  • Impact of Patient Navigation Interventions on Timely Diagnostic Follow Up for Abnormal Cervical Screening. 
  • Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data. 
  • Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. 
  • Impact of hysterectomy and bilateral oophorectomy prevalence on rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women, 1999-2004. 
  • Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study. 
  • Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. 
  • Impact of the National Breast and Cervical Cancer Early Detection Program on cervical cancer mortality among uninsured low-income women in the U.S., 1991-2007. 
  • Improving the sensitivity of cervical cytology: what are the issues? 
  • In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153). 
  • Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease. 
  • Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. 
  • Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). 
  • Increased Rate of ASCUS Diagnosis With Concomitant Request for High-Risk Human Papillomavirus Reflex Testing May Be Due to Cognitive Bias. 
  • Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. 
  • Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. 
  • Incremental and average cost-effectiveness ratios: will physicians make a distinction? 
  • Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy. 
  • Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A patterns of care study. 
  • Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women. 
  • Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act. 
  • Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. 
  • International Image Concordance Study to Compare a Point-of-Care Tampon Colposcope With a Standard-of-Care Colposcope. 
  • Intraoperative interstitial microwave-induced hyperthermia and brachytherapy. 
  • Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta. 
  • Invasive and in situ cervical cancer reported to the vaccine adverse event reporting system (VAERS). 
  • Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis. 
  • Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model. 
  • Knowledge about cervical cancer screening and perception of risk among women attending outpatient clinics in rural Kenya. 
  • Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO's Study on Global Ageing and Adult Health (SAGE). 
  • Long and short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery: comparison of flap-specific complications. 
  • Loop electrosurgical excision procedure: safety and tolerability among human immunodeficiency virus-positive Kenyan women. 
  • Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice. 
  • Major morbidity after pelvic exenteration: a seven-year experience. 
  • Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. 
  • Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts? 
  • Men's knowledge and attitudes about cervical cancer screening in Kenya. 
  • Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies. 
  • Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity. 
  • Microtubule stabilization and potentiation of taxol activity by the creatine analog cyclocreatine. 
  • Minimally Invasive Lymphadenectomy in Uterine Cervical Cancer: A Systematic Review. 
  • Mobile Technologies and Cervical Cancer Screening in Low- and Middle-Income Countries: A Systematic Review. 
  • Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution. 
  • Molecular characterization of adenocarcinoma of the cervix. 
  • Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5. 
  • Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. 
  • Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. 
  • Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer. 
  • Multimaterial three-dimensional printing in brachytherapy: Prototyping teaching tools for interstitial and intracavitary procedures in cervical cancers. 
  • Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. 
  • Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature. 
  • Neutrophils promote tumor resistance to radiation therapy. 
  • Non-randomized comparative study of irradiation alone or in combination with surgery in stage Ib, IIa and "proximal" IIb carcinoma of the cervix. 
  • Not just a woman's business! Understanding men and women's knowledge of HPV, the HPV vaccine, and HPV-associated cancers. 
  • Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis. 
  • Nuclear DNA study of vaginal and cervical squamous cell abnormalities in DES exposed progeny. 
  • Optical imaging of cervical pre-cancers with structured illumination: an integrated approach. 
  • Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. 
  • Oral contraceptive use and risk of cancer--response. 
  • PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model. 
  • PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. 
  • Pain predicts non-adherence to pap smear screening among middle-aged African American women. 
  • Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter? 
  • Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des). 
  • Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study. 
  • Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study. 
  • Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978. 
  • Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. 
  • Pediatricians are more supportive of the human papillomavirus vaccine than the general public. 
  • Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitro. 
  • Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study. 
  • Perinatal Considerations in Women With Previous Diagnosis of Cancer. 
  • Peritoneal cytology and invasive carcinoma of the cervix. 
  • Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study. 
  • Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology. 
  • Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women. 
  • Portable colposcopy in low-resource settings. 
  • Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. 
  • Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S. 
  • Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. 
  • Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation. 
  • Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies. 
  • Predisease: when does it make sense? 
  • Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study. 
  • Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort. 
  • Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. 
  • Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. 
  • Prenatal diethylstilbestrol exposure and human genital tract abnormalities. 
  • Prevalence of dysplasia and cancer of the cervix in a nationwide, planned parenthood population. 
  • Prevalence, characteristics, and outcomes of HIV-positive women diagnosed with invasive cancer of the cervix in Kenya. 
  • Primary HPV and Molecular Cervical Cancer Screening in US Women Living With Human Immunodeficiency Virus. 
  • Primary Health Care and Cervical Cancer Mortality Rates in Brazil: A Longitudinal Ecological Study. 
  • Primary care residents' characteristics and motives for providing differential medical treatment of cervical cancer screening. 
  • Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. 
  • Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. 
  • Psychometric validation and reliability analysis of a Spanish version of the patient satisfaction with cancer-related care measure: a patient navigation research program study. 
  • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. 
  • Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies. 
  • Quantitative physiology of the precancerous cervix in vivo through optical spectroscopy. 
  • RAD52 variants predict platinum resistance and prognosis of cervical cancer. 
  • Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening. 
  • Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. 
  • Radiation for Cancers of the Uterine Corpus and Cervix: Incremental Steps, and Glimmers of the Future. 
  • Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. 
  • Radical hysterectomy in obese women. 
  • Radical hysterectomy with preoperative intracavitary therapy for stage IB squamous cell carcinoma of the cervix. 
  • Rapid determination of oxygen saturation and vascularity for cancer detection. 
  • Recent developments in defining microinvasive and early invasive carcinoma of the uterine cervix. 
  • Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study. 
  • Relationship of epithelial ovarian cancer to other malignancies within families. 
  • Reproducibility of self-reported pap test utilization in middle-aged African-American women. 
  • Reproductive and maternal health in the post-2015 era: cervical cancer must be a priority. 
  • Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice. 
  • Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya. 
  • Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. 
  • Role of hormones including diethylstibestrol (DES) in the pathogenesis of cervical and vaginal intraepithelial neoplasia. 
  • SAbR as an Alternative Boost Modality for Cervical Cancer: A Cautionary Exercise. 
  • Safety of the loop electrosurgical excision procedure performed by clinical officers in an HIV primary care setting. 
  • Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. 
  • Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach. 
  • Screening and early detection among racial and ethnic minority women. 
  • Screening for cervical cancer: a modeling study for the US Preventive Services Task Force. 
  • Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). 
  • Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland. 
  • Self reported morbidity and awareness regarding common cancers in elderly women. 
  • Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma. 
  • Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening. 
  • Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. 
  • Soft tissue complication rates after low dose rate brachytherapy using customized perineal templates. 
  • Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol. 
  • Squamous cell neoplasia controversy in the female exposed to diethylstilbestrol. 
  • Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. 
  • Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya. 
  • Surgical candidacy and treatment initiation among women with cervical cancer at public referral hospitals in Kampala, Uganda: a descriptive cohort study. 
  • Systems-level barriers to treatment in a cervical cancer prevention program in Kenya: Several observational studies. 
  • Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer. 
  • Technologic advances for evaluation of cervical cytology: is newer better? 
  • Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia. 
  • The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes. 
  • The LAST guidelines in clinical practice: implementing recommendations for p16 use. 
  • The Unique Issues With Brachytherapy in Low- and Middle-Income Countries. 
  • The association of oncogenic human papillomaviruses with urologic malignancy. The controversies and clinical implications. 
  • The clinical significance of blood transfusion at the time of radical hysterectomy. 
  • The current and future role of screening in the era of HPV vaccination. 
  • The economic impact of HPV vaccines: not just cervical cancer. 
  • The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts. 
  • The impact of health status on physicians' intentions to offer cancer screening to older women. 
  • The impact of human papillomavirus vaccination on cervical cancer prevention efforts. 
  • The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. 
  • The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. 
  • The influence of cost-effectiveness information on physicians' cancer screening recommendations. 
  • The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. 
  • The nucleolar localization domain of the catalytic subunit of human telomerase. 
  • The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria: results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program. 
  • The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. 
  • The role of PET scanning in the detection of recurrent cervical cancer. 
  • The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females. 
  • The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. 
  • Three-dimensional applicator system for carcinoma of the uterine cervix. 
  • Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. 
  • Transperitoneal Versus Extraperitoneal Laparoscopic Lymphadenectomy for Gynecological Malignancies: A Systematic Review and Meta-analysis. 
  • Treatment of late complications of ileal conduit. 
  • Treatment of recurrent and metastatic cervical cancer with cis-platin, doxorubicin, and cyclophosphamide. 
  • Trichomonas vaginalis and cervical cancer. A prospective study in China. 
  • Tumoral calcium pyrophosphate dihydrate deposition disease mimicking a cervical spine neoplasm: case report. 
  • US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening. 
  • Ultrastructure of 16 cases of clear cell adenocarcinoma of the vagina and cervix in young women. 
  • Uterine perforation by an intracavitary tandem: CT demonstration. 
  • Utility scores and treatment preferences for clinical early-stage cervical cancer. 
  • Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy. 
  • Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population. 
  • Villoglandular adenocarcinoma of the cervix: a case report. 
  • Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Moorman, Patricia Gripka, Professor Emeritus in Family Medicine and Community Health, Duke Cancer Institute
  • Palmer, Gregory M., Associate Professor of Radiation Oncology, Radiation Oncology